VA
Visium Asset Management, LP
13F filer · CIK 0001377452Last filed Aug 12, 2016
Inactive · not filing 13F
13F portfolio value$0U.S. long equity reported on 13F
Positions251103 new · 227 closed
Net flow last quarterNot reportedBuys minus sells
Top 10 positions weight11.6%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2016Reported Aug 12, 2016251 positions | |||||
| $25.6M | 1.79% | 0.13% | Not reported | Q3 2013 | |
| AYHOOAltaba Inc. | $22.5M | 1.58% | 0.06% | -54.1% | Q2 2013 |
| $22.5M | 1.58% | 1.19% | Not reported | Q4 2013 | |
| QQTNTQuotient Limited | $18.4M | 1.29% | 9.33% | -4.2% | Q2 2014 |
| COCSODCornerstone OnDemand Inc | $15.1M | 1.06% | 0.71% | -28.7% | Q4 2014 |
| CTCTBCooper Tire & Rubber Co | $15M | 1.05% | 0.91% | +57.1% | Q2 2013 |
| EKWREvergy Kansas Central, Inc. | $13.4M | 0.94% | 0.17% | +56.9% | Q4 2013 |
| $12.3M | 0.86% | 0.01% | -57.1% | Q2 2013 | |
| $10.4M | 0.72% | 0.10% | +220.1% | Q4 2014 | |
| $10.2M | 0.71% | Not reported | +3.9% | Q3 2013 | |
| $9.88M | 0.69% | 0.03% | +242.6% | Q4 2013 | |
| ETETFCE Trade Financial Corp | $9.29M | 0.65% | 0.14% | +45.2% | Q2 2013 |
| SJSTJST Jude Medical, LLC | $9.27M | 0.65% | 0.04% | -65.9% | Q2 2013 |
| $9.19M | 0.64% | 0.02% | -59.7% | Q2 2013 | |
| $8.99M | 0.63% | 0.21% | +11.4% | Q1 2016 | |
| $8.88M | 0.62% | Not reported | -43.6% | Q1 2015 | |
| $8.86M | 0.62% | 0.01% | -72.6% | Q2 2013 | |
| $8.72M | 0.61% | 0.03% | -83.9% | Q3 2013 | |
| $8.63M | 0.60% | 0.01% | +107.7% | Q4 2015 | |
| $8.46M | 0.59% | 0.42% | Not reported | Q2 2013 | |
| $8.35M | 0.58% | 0.11% | -57.9% | Q2 2014 | |
| $8.21M | 0.57% | Not reported | Not reported | Q1 2016 | |
| $8.15M | 0.57% | 0.28% | New | Q2 2016 | |
| $8.05M | 0.56% | 0.46% | +2.5% | Q4 2015 | |
| $7.82M | 0.55% | 0.04% | -4.0% | Q2 2013 | |
| $7.77M | 0.54% | 0.01% | -40.7% | Q2 2013 | |
| $7.43M | 0.52% | 0.14% | -57.5% | Q1 2014 | |
| SSCGScana Corp | $7.41M | 0.52% | 0.07% | +219.4% | Q3 2013 |
| $7.41M | 0.52% | Not reported | New | Q2 2016 | |
| AUALJAlon USA Energy, Inc. | $7.19M | 0.50% | 1.56% | +2.5% | Q4 2013 |
| $6.99M | 0.49% | 0.01% | Not reported | Q3 2013 | |
| ARAJRDAerojet Rocketdyne Holdings, Inc. | $6.9M | 0.48% | Not reported | -4.1% | Q4 2015 |
| PPVTBPrivatebancorp, Inc | $6.84M | 0.48% | 0.20% | New | Q2 2016 |
| $6.73M | 0.47% | 0.06% | Not reported | Q4 2013 | |
| $6.72M | 0.47% | 1.03% | -54.8% | Q1 2015 | |
| $6.4M | 0.45% | Not reported | New | Q2 2016 | |
| CRCLRContinental Resources, Inc | $6.29M | 0.44% | 0.04% | -84.1% | Q2 2014 |
| PPRAProassurance Corp | $6.28M | 0.44% | 0.22% | -37.0% | Q2 2014 |
| $6.25M | 0.44% | Not reported | -43.3% | Q2 2013 | |
| VVRValidus Holdings Ltd | $6.24M | 0.44% | 0.16% | -70.1% | Q3 2013 |
| $6.2M | 0.43% | 0.01% | -79.0% | Q2 2014 | |
| $6.2M | 0.43% | 0.01% | -77.8% | Q3 2013 | |
| $5.98M | 0.42% | 0.02% | Not reported | Q2 2013 | |
| $5.85M | 0.41% | Not reported | Not reported | Q2 2013 | |
| $5.84M | 0.41% | 0.12% | -64.6% | Q4 2014 | |
| $5.36M | 0.37% | 0.07% | -41.9% | Q1 2014 | |
| $5.26M | 0.37% | 0.06% | -36.2% | Q1 2014 | |
| $5.17M | 0.36% | Not reported | -92.2% | Q3 2013 | |
| $5.13M | 0.36% | 0.05% | -32.2% | Q2 2013 | |
| $5.1M | 0.36% | 0.04% | +49.2% | Q2 2013 | |
| Q1 2016Reported May 16, 2016374 positions | |||||
| AAGNAllergan Inc | $264M | 4.49% | 0.32% | -10.1% | Q2 2013 |
| EHENDPEndo Health Solutions Inc. | $188M | 3.20% | 5.78% | +29.2% | Q2 2013 |
| $119M | 2.02% | 6.03% | -2.3% | Q2 2013 | |
| $104M | 1.76% | 0.99% | Not reported | Q4 2014 | |
| $99.3M | 1.69% | 0.17% | Not reported | Q2 2013 | |
| ZAZLTQZeltiq Aesthetics Inc | $78M | 1.33% | 7.29% | +17.3% | Q4 2013 |
| $73.7M | 1.25% | 2.15% | -15.3% | Q2 2013 | |
| $71.2M | 1.21% | Not reported | +109.5% | Q3 2013 | |
| $70.1M | 1.19% | Not reported | -22.6% | Q2 2013 | |
| $69.1M | 1.18% | 0.06% | +21319.8% | Q2 2013 | |
| $64.5M | 1.10% | 5.55% | -14.9% | Q2 2014 | |
| $63.6M | 1.08% | 0.03% | +29.3% | Q2 2013 | |
| $58.4M | 0.99% | 1.00% | +5.6% | Q2 2013 | |
| $58.4M | 0.99% | 0.16% | +88.9% | Q2 2013 | |
| CBCBPOChina Biologic Products Holdings, Inc. | $55.5M | 0.94% | Not reported | +14.7% | Q2 2013 |
| $55.1M | 0.94% | 0.20% | +400.3% | Q3 2013 | |
| SSPNCSpectranetics Corp | $52.2M | 0.89% | 8.40% | +54.3% | Q3 2013 |
| $51.9M | 0.88% | 0.24% | -44.4% | Q2 2013 | |
| $50.3M | 0.86% | Not reported | +16.3% | Q4 2014 | |
| STSAGESage Therapeutics, Inc. | $50M | 0.85% | 4.87% | +45.1% | Q1 2015 |
| $49.7M | 0.85% | 0.93% | +681.8% | Q1 2015 | |
| SGAXGTSio Gene Therapies Inc. | $48.1M | 0.82% | 5.59% | -17.4% | Q2 2015 |
| AYHOOAltaba Inc. | $48.1M | 0.82% | 0.14% | -9.0% | Q2 2013 |
| HTHZNPHorizon Therapeutics Public Ltd Co | $46.5M | 0.79% | 1.75% | -5.3% | Q1 2014 |
| $40.8M | 0.69% | 0.07% | +6.6% | Q2 2013 | |
| $40.8M | 0.69% | 11.41% | Not reported | Q2 2013 | |
| $38.1M | 0.65% | 1.26% | -60.0% | Q3 2013 | |
| $36.7M | 0.62% | 2.60% | -8.9% | Q1 2015 | |
| $36.3M | 0.62% | 0.06% | +90.8% | Q2 2013 | |
| $35.5M | 0.60% | Not reported | +542.8% | Q2 2013 | |
| BHBHIBaker Hughes Holdings LLC | $33.9M | 0.58% | 0.18% | +10.1% | Q2 2013 |
| $33.9M | 0.58% | 1.37% | -15.1% | Q1 2014 | |
| $33.8M | 0.57% | 0.02% | +221.3% | Q2 2013 | |
| $33.7M | 0.57% | 0.18% | -63.1% | Q2 2013 | |
| HHESHess Corp | $32.4M | 0.55% | Not reported | Not reported | Q2 2013 |
| $30.8M | 0.52% | 0.06% | +100.0% | Q3 2013 | |
| AMAMRIAlbany Molecular Research Inc | $30.7M | 0.52% | 5.61% | -4.3% | Q3 2013 |
| $29.5M | 0.50% | 0.02% | +18.6% | Q2 2013 | |
| $29M | 0.49% | 0.70% | Not reported | Q2 2013 | |
| $29M | 0.49% | 0.13% | +58.1% | Q2 2013 | |
| $28.3M | 0.48% | 0.13% | -33.4% | Q2 2013 | |
| $27.4M | 0.47% | 0.06% | +24.2% | Q2 2014 | |
| CRCLRContinental Resources, Inc | $26.5M | 0.45% | 0.23% | +51.4% | Q2 2014 |
| $26.1M | 0.44% | Not reported | +2.7% | Q1 2015 | |
| $25.4M | 0.43% | Not reported | Not reported | Q4 2013 | |
| LJLJPCLa Jolla Pharmaceutical Co | $24.8M | 0.42% | 6.50% | +88.4% | Q3 2014 |
| $24.7M | 0.42% | 0.16% | Not reported | Q2 2014 | |
| ITITCIIntra-Cellular Therapies, Inc. | $24.5M | 0.42% | 2.04% | -12.3% | Q1 2014 |
| XXLXL Group Ltd | $24M | 0.41% | 0.23% | +33.1% | Q4 2013 |
| $23.2M | 0.40% | 0.03% | -6.7% | Q2 2013 | |
| Q4 2015Reported Feb 12, 2016419 positions | |||||
| AAGNAllergan Inc | $342M | 5.14% | 0.36% | +9.9% | Q2 2013 |
| EHENDPEndo Health Solutions Inc. | $317M | 4.76% | 4.47% | -0.6% | Q2 2013 |
| $176M | 2.64% | 6.22% | -22.4% | Q2 2013 | |
| $125M | 1.87% | 2.55% | +0.1% | Q2 2013 | |
| $111M | 1.66% | 3.18% | +278.4% | Q3 2013 | |
| $103M | 1.55% | 0.50% | -60.4% | Q2 2013 | |
| SGAXGTSio Gene Therapies Inc. | $91.5M | 1.38% | 5.12% | -1.6% | Q2 2015 |
| $89.8M | 1.35% | 0.43% | +7.5% | Q2 2013 | |
| $83M | 1.25% | Not reported | -3.1% | Q2 2013 | |
| $79.6M | 1.20% | 6.52% | -22.7% | Q2 2014 | |
| $70.7M | 1.06% | 1.62% | -0.2% | Q1 2014 | |
| ZAZLTQZeltiq Aesthetics Inc | $69.9M | 1.05% | 6.24% | +95.2% | Q4 2013 |
| $66.7M | 1.00% | 3.08% | +2.0% | Q1 2015 | |
| HTHZNPHorizon Therapeutics Public Ltd Co | $64.2M | 0.96% | 1.85% | +65.5% | Q1 2014 |
| STSAGESage Therapeutics, Inc. | $62.7M | 0.94% | 3.73% | +19.1% | Q1 2015 |
| $61.9M | 0.93% | Not reported | +1.0% | Q4 2014 | |
| CBCBPOChina Biologic Products Holdings, Inc. | $60.2M | 0.90% | Not reported | -18.2% | Q2 2013 |
| ITITCIIntra-Cellular Therapies, Inc. | $54M | 0.81% | 2.32% | +1.3% | Q1 2014 |
| $53.6M | 0.80% | 0.03% | +68.0% | Q2 2013 | |
| $50.1M | 0.75% | 0.96% | -44.4% | Q2 2013 | |
| AYHOOAltaba Inc. | $47.7M | 0.72% | 0.15% | +36.7% | Q2 2013 |
| $47.4M | 0.71% | 0.34% | +5.7% | Q3 2013 | |
| $45.4M | 0.68% | 0.09% | +107.0% | Q2 2013 | |
| $43.8M | 0.66% | 0.06% | +76.3% | Q2 2013 | |
| $43.4M | 0.65% | 0.12% | Not reported | Q4 2014 | |
| AMAMRIAlbany Molecular Research Inc | $41.7M | 0.63% | 5.10% | -36.4% | Q3 2013 |
| $41M | 0.62% | 11.44% | Not reported | Q2 2013 | |
| $39.4M | 0.59% | 0.19% | +5806.7% | Q2 2013 | |
| $38.8M | 0.58% | 0.09% | -69.2% | Q2 2013 | |
| PCPCPPrecision Castparts Corp | $36.3M | 0.55% | 0.11% | +2.8% | Q3 2013 |
| $36.2M | 0.54% | Not reported | -76.1% | Q3 2013 | |
| $35.3M | 0.53% | 0.20% | +232.5% | Q2 2013 | |
| SSPNCSpectranetics Corp | $35.1M | 0.53% | 5.46% | +19.4% | Q3 2013 |
| QQTNTQuotient Limited | $32.5M | 0.49% | 9.68% | +21.3% | Q2 2014 |
| BHBHIBaker Hughes Holdings LLC | $32.4M | 0.49% | 0.16% | +7.3% | Q2 2013 |
| $31.1M | 0.47% | 0.18% | -16.5% | Q3 2013 | |
| $30.9M | 0.46% | 0.85% | +0.7% | Q2 2013 | |
| $30.8M | 0.46% | 0.05% | Not reported | Q3 2013 | |
| $29.7M | 0.45% | 0.21% | +245.1% | Q2 2013 | |
| $27.2M | 0.41% | 0.03% | -25.5% | Q2 2013 | |
| BMBPMCBlueprint Medicines Corporation | $26.9M | 0.40% | 3.77% | Not reported | Q2 2015 |
| $25.9M | 0.39% | 0.10% | +12327.4% | Q4 2013 | |
| $25.7M | 0.39% | 0.10% | +5371.6% | Q1 2015 | |
| NNVRONevro Corp. | $25.5M | 0.38% | 1.34% | +67.6% | Q4 2014 |
| $25.5M | 0.38% | Not reported | -39.1% | Q2 2013 | |
| $25.4M | 0.38% | 0.08% | +99.0% | Q3 2013 | |
| $25.2M | 0.38% | 0.02% | -8.4% | Q2 2013 | |
| $25.1M | 0.38% | Not reported | Not reported | Q1 2015 | |
| $24M | 0.36% | 2.95% | +1349.2% | Q1 2015 | |
| AAKRXQAkorn Inc | $23.6M | 0.35% | Not reported | +917.3% | Q1 2015 |
| Q3 2015Reported Nov 16, 2015691 positions | |||||
| EHENDPEndo Health Solutions Inc. | $361M | 4.92% | 4.50% | +40.2% | Q2 2013 |
| $284M | 3.88% | 1.23% | -13.7% | Q2 2013 | |
| AAGNAllergan Inc | $271M | 3.70% | 0.32% | +43445.9% | Q2 2013 |
| VPVRXValeant Pharmaceuticals International | $184M | 2.51% | 1.36% | +24.1% | Q2 2013 |
| $140M | 1.91% | Not reported | Not reported | Q3 2013 | |
| $121M | 1.66% | 8.03% | +380.1% | Q2 2013 | |
| $118M | 1.61% | 0.28% | +133.4% | Q2 2013 | |
| $112M | 1.53% | 8.44% | -0.1% | Q2 2014 | |
| APAETAetna Inc | $103M | 1.40% | 0.27% | -23.6% | Q2 2013 |
| MPMNTAMomenta Pharmaceuticals Inc | $88.6M | 1.21% | 7.84% | +30.4% | Q2 2013 |
| $87.5M | 1.20% | 2.56% | +9.6% | Q2 2013 | |
| $85.2M | 1.16% | 2.32% | +492.4% | Q2 2013 | |
| $77.9M | 1.06% | Not reported | +10.2% | Q2 2013 | |
| $77.7M | 1.06% | 1.72% | +35.3% | Q2 2013 | |
| $76.5M | 1.04% | 0.40% | -18.8% | Q2 2013 | |
| COCLVSClovis Oncology, Inc. | $71.9M | 0.98% | 2.04% | +4.1% | Q2 2013 |
| SGAXGTSio Gene Therapies Inc. | $66.7M | 0.91% | 5.20% | +1.6% | Q2 2015 |
| $65M | 0.89% | 0.09% | +8121.5% | Q2 2013 | |
| $60.8M | 0.83% | 1.63% | -5.6% | Q1 2014 | |
| AMAMRIAlbany Molecular Research Inc | $57.5M | 0.79% | 9.31% | +3.1% | Q3 2013 |
| $48.1M | 0.66% | 0.23% | +27.1% | Q2 2013 | |
| CBCBPOChina Biologic Products Holdings, Inc. | $46.4M | 0.63% | Not reported | +3.2% | Q2 2013 |
| $44.1M | 0.60% | Not reported | +28.1% | Q4 2014 | |
| XXLXL Group Ltd | $44M | 0.60% | 0.40% | +3.2% | Q4 2013 |
| $43.5M | 0.59% | 3.04% | -3.8% | Q1 2015 | |
| $43M | 0.59% | 0.32% | +352.7% | Q3 2013 | |
| ZAZLTQZeltiq Aesthetics Inc | $40.2M | 0.55% | 3.22% | +218.9% | Q4 2013 |
| ITITCIIntra-Cellular Therapies, Inc. | $39.7M | 0.54% | 2.30% | -5.8% | Q1 2014 |
| $39.6M | 0.54% | Not reported | +994.6% | Q1 2015 | |
| STSAGESage Therapeutics, Inc. | $38.2M | 0.52% | 3.14% | +37.5% | Q1 2015 |
| $37.1M | 0.51% | Not reported | +33.3% | Q2 2013 | |
| $36.4M | 0.50% | 0.84% | -36.1% | Q3 2013 | |
| $36.3M | 0.50% | 11.48% | Not reported | Q2 2013 | |
| $36.1M | 0.49% | 0.04% | +11418.2% | Q2 2013 | |
| HTHZNPHorizon Therapeutics Public Ltd Co | $35.5M | 0.48% | 1.12% | +6.3% | Q1 2014 |
| $35.4M | 0.48% | 0.16% | +25.6% | Q2 2013 | |
| PCPCPPrecision Castparts Corp | $35M | 0.48% | 0.11% | +8916.8% | Q3 2013 |
| $34.9M | 0.48% | 0.83% | +142.4% | Q4 2013 | |
| BHBHIBaker Hughes Holdings LLC | $34.1M | 0.47% | 0.15% | +31.1% | Q2 2013 |
| IMALRInverness Medical Innovations Inc | $33.9M | 0.46% | 0.82% | +36.6% | Q4 2013 |
| $33.5M | 0.46% | 0.22% | -39.3% | Q3 2013 | |
| $31M | 0.42% | 0.02% | +335.0% | Q2 2013 | |
| AYHOOAltaba Inc. | $30.3M | 0.41% | 0.11% | +20.4% | Q2 2013 |
| KHKNDKindred Healthcare, Inc | $29.2M | 0.40% | 2.21% | -4.8% | Q4 2014 |
| $28.7M | 0.39% | 0.06% | +19.3% | Q2 2014 | |
| $28.6M | 0.39% | 0.69% | +10.7% | Q2 2013 | |
| $28.5M | 0.39% | 0.85% | +3.0% | Q2 2013 | |
| $26.2M | 0.36% | 2.94% | -8.0% | Q4 2014 | |
| $24.7M | 0.34% | 0.02% | +55.3% | Q2 2013 | |
| $24.2M | 0.33% | Not reported | +437.3% | Q1 2015 | |
Premium opens every quarter this fund has filed